ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth vs ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Direct Plan Growth

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth appears stronger in terms of returns, with a 1-year return of 24.97% and a 3-year CAGR of 21.58%, compared to ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Direct Plan Growth's 1-year return of 5.4% and a 3-year CAGR of 7.39%. However, the latter fund has a significantly lower expense ratio of 0.2% and a higher AUM of ₹7771 Cr, indicating greater investor confidence and potentially lower costs over time. Investors should weigh the higher potential returns of the Pharma Index Fund against the lower costs and higher rating of the PSU Bond Fund when making a choice.

ICICI Prudential Mutual Fund

ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth

ICICI Prudential Mutual Fund

★★★★★

Other · Index Funds

ICICI Prudential Mutual Fund

ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Direct Plan Growth

ICICI Prudential Mutual Fund

★★★★★

Other · Index Funds

Metric ICICI Prudential Nifty... ICICI Prudential Nifty...
NAV ₹21.96 ₹13.49
Star Rating ★★ ★★★★★
Expense Ratio 0.51% 0.2%
AUM ₹163 Cr ₹7,771 Cr
1M Return +10.74% +0.48%
3M Return +7.74% +0.93%
6M Return +14.27% +3.13%
1Y Return +24.97% +5.4%
3Y CAGR +21.58% +7.39%
5Y CAGR — +6.1%
Risk Level — —
Fund Manager Nishit Patel Anuj Tagra